ZVRA: Strong commercial growth, expanding rare disease reach, and robust financials drive future milestones

The organization is rapidly expanding its rare disease portfolio, with strong commercial momentum for its lead therapy, robust patient support, and a growing addressable market. Financial strength and disciplined strategy underpin ongoing U.S. and global expansion, with key regulatory milestones ah…